Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Emergent Biosolutions

(NYSE: EBS)
Add to Portfolio
+0.61 (+11.98%)
as of May 31, 2024

Last 5.70
Change +0.61 (+11.98%)
Open 5.13
Prev. Close 5.09
Today's Range
5.04
5.72
52wk Range
1.42
9.96
Volume 2,467,500
Avg Volume 4,026,580
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
EBS +11.98% +127.09% -30.23%
DJIA +1.51% -2.09% +16.90%
S&P 500 +0.80% +1.01% +25.49%

Key Statistics

Annual EPS -11.01
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 243,150
Weighted Alpha -64.17
Standard Deviation +1.41
Profit Margin -47.68%
Beta 1.24

Growth Rates

YTD +137.50%
1-Year -30.83%
3-Year -91.15%
5-Year -87.74%
10-Year -73.72%

Opinion

Sell Hold Buy

Recent Headlines

Emergent Biosolutions: Q2 Earnings Snapshot

AP - Mon Aug 01, 04:03PM CDT
GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Monday reported a second-quarter loss of $56.4 million, after reporting a profit in the same period a year earlier.(full story)
EBS: 5.70 (+0.61)

Emergent Biosolutions: Q1 Earnings Snapshot

AP - Thu Apr 28, 03:22PM CDT
GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Thursday reported a first-quarter loss of $3.7 million, after reporting a profit in the same period a year earlier.(full story)
EBS: 5.70 (+0.61)

Emergent Biosolutions: Q4 Earnings Snapshot

AP - Thu Feb 24, 03:55PM CST
GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Thursday reported fourth-quarter profit of $189.3 million.(full story)
EBS: 5.70 (+0.61)